Efficacy of glimepiride in type 2 diabetic patients treated with glibenclamide

被引：32
|
作者：
Hamaguchi, T [1 ]
Hirose, T [1 ]
Asakawa, H [1 ]
Itoh, Y [1 ]
Kamado, K [1 ]
Tokunaga, K [1 ]
Tomita, K [1 ]
Masuda, H [1 ]
Watanabe, N [1 ]
Namba, M [1 ]
机构：
[1] Hyogo Med Univ, Dept Internal Med, Div Diabet & Metab, Nishinomiya, Hyogo 6638501, Japan
来源：
DIABETES RESEARCH AND CLINICAL PRACTICE | 2004年 / 66卷
关键词：
third-generation sulfonylurea; extrapancreatic effects; insulin resistance; metabolic syndrome;
D O I：
10.1016/j.diabres.2003.12.012
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Multicentric study was conducted to evaluate the efficacy of glimepiride in the oral hypoglycemic agents therapy of type 2 diabetic patients treated with glibenclamide so far, and to claim an adequate use of this new generation sulfonylurea. In 66 diabetic outpatients, glibenclamide was switched to glimepiride. After 6 months' therapy, a significant reduction in fasting plasma IRI was observed in relatively hyperinsulinemic patients. In addition, weight reduction was achieved in patients with insulin resistance during this study. These findings suggest that glimepiride improves insulin resistance in hyperinsulinemic patients treated with glibenclamide. Also, glimepiride is favored especially for overweight, insulin-resistant patients inadequately controlled by glibenclamide. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码：S129 / S132
页数：4
相关论文
共 50 条
  • [31] Repaglinide, glibenclamide and glimepiride administration to normal and hereditarily diabetic rats
    Ladriere, L
    MalaisseLagae, F
    Fuhlendorff, J
    Malaisse, WJ
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 335 (2-3) : 227 - 234
  • [32] CLINICAL AND METABOLIC STUDY IN DIABETIC PATIENTS TREATED WITH GLIBENCLAMIDE
    ANDERSON, J
    COULSON, R
    GRASSICK, BD
    MORRIS, BA
    THOMAS, WD
    TOMLINSON, RW
    WOODROFFE, F
    BMJ-BRITISH MEDICAL JOURNAL, 1970, 2 (5709): : 568 - +
  • [33] Clinical Investigation of Treatment Failure in Type 2 Diabetic Patients Treated with Metformin and Glibenclamide at a Hospital in Northwestern Nigeria
    Abubakar, Bilyaminu
    Giaze, Rabiu T.
    Haliru, Ahmad
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2014, 13 (09) : 1521 - 1526
  • [34] Efficacy and safety of glimepiride plus metformin in a single presentation, as combined therapy, in patients with type 2 diabetes mellitus and secondary failure to glibenclamide, as monotherapy
    González-Ortiz, M
    Martínez-Abundis, E
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2004, 56 (03): : 327 - 333
  • [35] Self-efficacy evaluation in type 2 diabetic patients treated with insulin
    Caramona, M.
    Patrao, M. C.
    Carvalheiro, M.
    Relvas, J.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (06) : 1327 - 1327
  • [36] Lower occurrence of low blood glucose level in elderly type 2 diabetic patients treated with gliclazide versus glibenclamide
    Oba, Kenzo
    Inuzuka, Yuki
    Yamashita-Onodera, Naoko
    Watanabe, Kentaro
    Matsumura, Noriaki
    Igari, Yoshimasa
    Suzuki, Tatsuya
    Nakano, Hiroshi
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2007, 7 (01) : 91 - 93
  • [37] Comparing Kidney Outcomes in Type 2 Diabetes Patients Treated with Gliclazide and Glimepiride
    Lee, Yong-Ho
    Lee, Chan Joo
    Choe, Eun Yeong
    Park, Sehee
    Bae, Jaehyun
    Kim, Gyuri
    Yun, Yu Jung
    Lee, Byung-Wan
    Ahn, Chul Woo
    Cha, Bong Soo
    Lee, Hyun Chul
    Balkau, Beverley
    Kang, Eun Seok
    DIABETES, 2014, 63 : A378 - A378
  • [38] COMPARING KIDNEY OUTCOMES IN TYPE 2 DIABETES PATIENTS TREATED WITH GLICLAZIDE AND GLIMEPIRIDE
    Kang, E. S.
    Lee, Y. -H.
    Kim, G.
    Lee, B. -W.
    Ahn, C. W.
    Cha, B. S.
    Lee, H. C.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S126 - S126
  • [39] EFFICACY AND SAFETY OF LIRAGLUTIDE IN JAPANESE TYPE 2 DIABETIC PATIENTS TREATED OVER 2 YEARS
    Shimizu, H.
    Akiyama, H.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S5 - S5
  • [40] ANTIARRHYTHMIC EFFICACY OF THE GLIBENCLAMIDE ON THE ISCHEMIC ARRHYTHMIAS IN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS
    CACCIAPUOTI, F
    GENTILE, S
    VERZA, M
    SPIEZIA, R
    DAVINO, M
    VARRICCHIO, M
    DIABETOLOGIA, 1988, 31 (07) : A476 - A476
12345